Fluticasone Furoate Ellipta

Fluticasone Furoate Ellipata is a prescription inhaled corticosteroid used for maintenance treatment of asthma in adults and children 5 years of age and older. It helps support long-term asthma control and is not used for sudden breathing symptoms.

• Generic name: fluticasone furoate
• Supplied as an inhalation powder in an Ellipata dry powder inhaler
• Available on this page in 100 mcg and 200 mcg strengths
• Used regularly as part of a provider-directed asthma treatment plan
• Not a rescue inhaler and not for acute bronchospasm

A licensed provider can review your asthma history, current medications, and safety factors to decide whether this treatment may be appropriate.

Fluticasone Furoate Ellipata is inhaled by mouth using the Ellipata inhaler. It is typically used once daily at the same time each day, exactly as prescribed by your healthcare provider.

• Do not use it more than once every 24 hours
• Rinse your mouth with water after use and spit it out
• Do not use it for sudden asthma symptoms
• Use rescue medicine for quick relief if your provider has prescribed it
• Do not change your dose or stop treatment unless your provider tells you to

Maximum benefit may take up to 2 weeks or longer, and individual response can vary.

Fluticasone Furoate Ellipata can cause side effects. Some common side effects may include upper respiratory tract infection, bronchitis, sore throat or throat irritation, viral infection, and headache.

• Rinsing your mouth after use can help lower the chance of a fungal infection in the mouth or throat
• Contact your provider if your asthma worsens or your rescue inhaler does not work as well
• Seek urgent care for serious allergic symptoms, severe breathing trouble, or sudden worsening after using the inhaler
• Tell your provider about milk protein allergy, infections, liver problems, eye problems, weak bones, pregnancy, or breastfeeding
• Children using inhaled corticosteroids may need growth monitoring

See Important Safety / Prescribing Information for full datail.

Fluticasone Furoate Ellipata is used as a regular maintenance inhaler for asthma in adults and children 5 years of age and older. It is designed for ongoing asthma control, not quick relief.

A licensed provider will review your asthma history, current medicines, age, symptoms, and safety factors before deciding whether this inhaler is appropriate. The 100 mcg and 200 mcg strengths shown on this page may not be right for every patient.

Tell the provider about any allergy to milk proteins, fluticasone furoate, or any inhaler ingredients. Also mention infections, tuberculosis history or exposure, chickenpox or measles exposure, liver problems, eye problems, weak bones, pregnancy, breastfeeding, or immune system concerns.

Share all medications you take, including prescription drugs, OTC medicines, vitamins, and supplements. Some medicines, including strong CYP3A4 inhibitors such as ketoconazole, may increase the risk of steroid-related side effects.

Yes. Fluticasone Furoate Ellipata requires a prescription. Online access still starts with a licensed provider reviewing your health information.

If treatment is appropriate, the provider may prescribe it for pharmacy fulfillment. If it is not appropriate, they may recommend another next step based on your asthma needs and medical history.

No. Fluticasone Furoate Ellipata is not for sudden asthma symptoms or acute bronchospasm.

Use your rescue medicine as directed by your provider. Seek urgent medical help if your breathing symptoms are severe, getting worse, or not improving with your usual rescue treatment.

Rinse your mouth with water and spit it out after each use. This helps lower the chance of getting a fungal infection in the mouth or throat.

Contact your provider if you notice white patches, soreness, irritation, or other unusual mouth or throat symptoms while using this inhaler.

Maximum benefit may take up to 2 weeks or longer, and response can vary from person to person. This inhaler should be used consistently as prescribed.

Do not increase your dose, use it more than once every 24 hours, or stop treatment unless your provider tells you to.

You should not use Fluticasone Furoate Ellipata if you have a severe allergy to milk proteins. The Ellipata inhaler contains ingredients that make this allergy important to discuss before treatment.

Tell the provider about any past allergic reactions to inhalers, medicines, milk proteins, or other ingredients before starting the consultation.

Fluticasone Furoate ELLIPTA Inhalation Powder - official prescribing information covering asthma maintenance treatment, dosage, warnings, adverse reactions, and safety information. / Source: DailyMed, U.S. National Library of Medicine Link: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3e797fc-2636-49a0-b89e-5246b18ee440 / Updated: March 6, 2025 / Revised: March 2025.